Harmony Biosciences Holdings, Inc. (HRMY)
Pharmaceutical Preparations · Healthcare · $2.0B
Intrinsic Value (Consensus)
$57.04
Current Price
$33.83
Margin of Safety
+68.6%
68.6% Below Intrinsic Value
Value: $57
Price: $34
Valuation Model Estimates
Current Price: $33.83
DCF (Discounted Cash Flow)
$117.36
Graham Number
$30.28
Earnings Power Value
$26.31
Relative Value (P/E)
$54.20
Dividend Discount Model
Not applicable
—
Consensus Value
$57.04
Model Assumptions
Discount Rate
10.3%
Growth Rate
8.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
A
87
Profitability
22/25
Strength
24/25
Valuation
22/25
Growth
19/25
Financial Health Signals
Low debt — conservative balance sheet
High free cash flow yield (17.8%) — generating lots of cash relative to price
Key Financials
- EPS (TTM)
- $2.71
- EPS (Forward)
- $2.93
- Book Value
- $15.04
- P/E Ratio
- 20.0
- Forward P/E
- 18.5
- PEG Ratio
- —
- ROE
- 18.2%
- Debt/Equity
- 19%
- Revenue Growth
- 21.5%
- Earnings Growth
- 8.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance